Overview
Proteomics of metabolic liver disorders is the large-scale study of the proteins expressed in the liver and circulation under metabolic disease, aiming to map how protein abundance, modification, and interaction change as hepatic metabolism is disturbed. The liver is central to lipid, carbohydrate, and protein metabolism, and disorders such as fatty liver disease, alcohol-related injury, and related metabolic conditions alter the hepatic proteome in ways that illuminate underlying pathways and may yield diagnostic and therapeutic targets. The field relies on mass-spectrometry-based proteomics, including quantitative strategies such as stable-isotope labeling and ion-current-based and label-free approaches, together with bioinformatic interpretation, to discover and measure proteins, characterize the response to drugs and stressors, and compare healthy and diseased states. Studies of liver enzymes and circulating markers, for example plasma proteins linked to alcohol use and genetic polymorphism, illustrate how proteomic and biomarker analysis connects molecular changes to clinical phenotype. By quantifying differential protein expression and integrating it with genomic information, this work seeks to define the molecular signatures of metabolic liver injury, clarify mechanisms of disease progression, and identify candidate biomarkers for diagnosis and monitoring. Proteomics of metabolic liver disorders thus joins analytical chemistry, hepatology, and systems biology to interpret how metabolic stress reshapes the protein landscape of the liver and the blood.
Research published in this journal
9 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Human Proteome Project and Current Bioinformatics Status in Disease Diagnosis and Treatment
Proteomic and Genomic Techniques in Medical Research: Applications in Cancer, Diagnostics, and Personalized Medicine
Quantitative Proteomics Using 15N SILAC Mouse
Discovery and Quantification in Mass Spectrometry-Based Proteomics
Determination of the Proteomic Response to Lapatinib Treatment using a Comprehensive and Reproducible Ion-Current-Based Proteomics Strategy
Carbofuran Abrogates the Membrane Ca++-Atpase Activity in Liver: The Role of Cholesterol
Shotgun Label-Free Proteomic Analyses of the Oyster Parasite Perkinsus Marinus
Bioinformatic Analysis of Coronary Disease Associated SNPs and Genes to Identify Proteins Potentially Involved in the Pathogenesis of Atherosclerosis
How this research is being cited
The 9 articles above have been cited 58 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · Biochemical Pharmacology
-
2026 · Alcohol and Alcoholism
-
2026 · BMC Bioinformatics
-
Hami Hemati et al. · 2025 · Brain, behavior, and immunity
-
2025 · Chemical Communications
-
2025 · Computational and Structural Biotechnology Journal
-
2025 · Journal of Molecular Structure
-
2025 · Brain Behavior and Immunity
A sample of recent works citing this journal's research on Proteomics of Metabolic Liver Disorders, linking to each citing work.